Kezar Life Sciences, Inc.
Home
About Us
Overview
Management Team
Board of Directors
Clinical Advisory Committee
Pipeline
Overview
KZR-616
KZR-261
Our Science
Overview
Medical & Scientific Presentations
Publications
Clinical Trials
Investors & News
Overview
News & Events
Company Info
Financial Info
Stock Data
SEC Filings
Governance
Careers
Contact Us
Medical & Scientific Presentations
Our Science
Our Science
Overview
Medical & Scientific Presentations
Publications
Nov 4, 2017
KZR-616 Blocks Disease Progression in Multiple Models of SLE
Kezar Life Sciences, Inc.
Nov 4, 2017
KZR-616 Shows Promising Safety and Target Inhibition Profile
Kezar Life Sciences, Inc.
« Previous
1
2
3
4
